Telemedicine in French memory clinics during the COVID-19 pandemic

Manuscript Number: 

21-5459R1

Author(s): 
Mathieu Ceccaldi, Emmanuel Cognat, Julien Dumurgier, Olivier Godefroy, Julien Grosjean, Julien Lagarde, Thibaud Lebouvier, David Maltête, Olivier Martinaud, Alexandre Morin, Pauline Olivieri, Claire Paquet, Florence Pasquier, Thibaut Pressat-Laffouilhere, Carole Roue-Jagot, Marie Sarazin, David Wallon, Aline Zarea

Disclosures

Mathieu Ceccaldi

  • Nothing to Disclose

Emmanuel Cognat

  • Nothing to Disclose

Julien Dumurgier

  • Nothing to Disclose

Olivier Godefroy

  • Consulting Fees:
    during the last five years has served on scientific advisory boards and speaker (Novartis, CSL-Behring, Biogen, Genzyme, Lilly, Bristol-Myers Squibb, Boehringer-Ingelheim, Covidien, Teva and Astra Zeneca), received funding for travel and meetings from Novartis, Lilly, Genzyme, Astrazeneca, Biogen, Teva, Pfizer, CSL-Behring, GSK, Boehringer-Ingelheim, Ipsen, Covidien, Bristol-Myers Squibb.

Julien Grosjean

  • Nothing to Disclose

Julien Lagarde

  • Nothing to Disclose

Thibaud Lebouvier

  • Nothing to Disclose

David Maltête

  • Nothing to Disclose

Olivier Martinaud

  • Nothing to Disclose

Alexandre Morin

  • Nothing to Disclose

Pauline Olivieri

  • Nothing to Disclose

Claire Paquet

  • Nothing to Disclose

Florence Pasquier

  • Nothing to Disclose

Thibaut Pressat-Laffouilhere

  • Nothing to Disclose

Carole Roue-Jagot

  • Nothing to Disclose

Marie Sarazin

  • Grants
    • Agency: 
      Institut Roche
      Dates: 
      2014-2017; 2020
    • Agency: 
      Servier
      Dates: 
      2017-2020

David Wallon

  • Nothing to Disclose

Aline Zarea

  • Nothing to Disclose